Skip to content
Open access · CC-BY via OpenAlex

Glycemic and Extraglycemic Effects of Metformin in Patients with Diabetes

Dario Rahelić, Zrinka Šakić

IntechOpen eBooks · 2023

Abstract

For several decades, metformin has been the mainstay of treatment of type 2 diabetes (T2D), not only due to its remarkable efficacy in both monotherapy and combination therapy regimens, but also due to its favorable safety profile, weight neutrality, and low cost. Other advantages have been reported, including improvements in lipid profile and inflammatory markers and reports of cardioprotective effects, albeit with scant evidence. The modification of the cellular energy metabolism is the core of metformin’s mode of action. Metformin works to lower serum glucose concentration by inhibiting hepatic gluconeogenesis and countering the action of glucagon. Secondarily, it enhances glucose uptake in peripheral tissues, predominantly in the muscles. Long-term and widespread use of metformin has shed light on its other potential uses mediated by its effects on deranged metabolic pathways. Moreover, metformin is gaining research interest by demonstrating its potential in the treatment of multiple disorders other than diabetes and has been proven to have anti-cancer, immunoregulatory, and anti-aging properties. As a result, metformin is currently being researched as a potential treatment option for various diseases.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.5772/intechopen.109357
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Rahelić, D., &amp; Šakić, Z. (2023). Glycemic and Extraglycemic Effects of Metformin in Patients with Diabetes. <em>IntechOpen eBooks</em>. https://doi.org/10.5772/intechopen.109357
Vancouver
Rahelić D, Šakić Z. Glycemic and Extraglycemic Effects of Metformin in Patients with Diabetes. IntechOpen eBooks. 2023. doi:10.5772/intechopen.109357.
BibTeX
@article{dario2023Glycem, title = {Glycemic and Extraglycemic Effects of Metformin in Patients with Diabetes}, author = {Dario Rahelić and Zrinka Šakić}, journal = {IntechOpen eBooks}, year = {2023}, doi = {10.5772/intechopen.109357}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings